drugset / Trial / NCT00696826

A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)

NCT00696826

Phase 1 Completed 20 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

A study to compare the plasma concentrations of MK0431 at different times in patients with hepatic insufficiency vs healthy control subjects.

Timeline

Start
2004-04
Primary completion
2004-05
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 100 mg Oral

Indications